---
schema_version: "secwatch.filing_event.v1"
accession: "0000078003-26-000005"
form_type: "8-K"
ticker: "PFE"
cik: "0000078003"
company_name: "PFIZER INC"
filed_at: "2026-02-03T23:59:59+00:00"
generated_at: "2026-05-16T05:29:58.772559+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Pfizer reports FY2025 revenue $62.6B, adj. EPS $3.22; reaffirms FY2026 guidance

## Summary
- Full-year 2025 revenue $62.6B (-2% operational); non-COVID portfolio +6% operational.
- FY2025 reported diluted EPS $1.36; adjusted diluted EPS $3.22 (+4% YoY).
- Q4 2025 revenue $17.6B (-1%); Q4 reported LPS ($0.29); adj. diluted EPS $0.66.
- Completed Metsera acquisition (~$7B); ViiV stake sale for $1.875B; reaffirms FY2026 revenue guidance $59.5-62.5B, adj. EPS $2.80-3.00.

## SEC filing metadata
- accession: 0000078003-26-000005
- form_type: 8-K
- ticker: PFE
- cik: 0000078003
- company_name: PFIZER INC
- filed_at: 2026-02-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/78003/000007800326000005/0000078003-26-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/78003/000007800326000005/pfe-20260203.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000078003-26-000005
- JSON: https://secwatch.observer/filing/0000078003-26-000005.json
- Plain text: https://secwatch.observer/filing/0000078003-26-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.